Background & objectives
As far as the records are available or the traditional knowledge tells us that the 1st known epidemic of infectious disease (ID) is over 3000 years old. We have seen since then, a basket of varieties of infection such as Small Pox, Plague, Cholera, Typhoid, Chikungunya, Meningitis, MERS-CoV, Nipah virus, hemorrhagic fever, West Nile fever, Yellow fever, Zika virus, HIV, Ebola virus, Dengue, Avian Influenza A(H5N1), Swine Flu, SARS, and now novel Corona –COVID-2019 along with that we have standing threats of other infectious diseases such as TB, malaria, variants of common flu and other neglected and re-emerging IDs.
While a comparative trend analysis of the transmission of select IDs that became epidemic or pandemic during its reign is imperative but a detailed one is yet to come. The IDs are caused by microbial organisms that are pathogenic.
On the contrary, the human body harbors a multitude of microbes that can easily outnumber the number of pathogens that caused havoc in human society. Many of these resident microbes are also beneficial to our physiology to maintain health. Although progress has been made in studying microbiome their therapeutic or prophylactic abilities have only started to emerge. The role of microbes has already shown protective roles against colitis or other enteric diseases.
The present-day world is going through a huge crisis of COVID-19 pandemic. While mankind is in search of vaccines or effective medication against COVID, it is only tantamount to think if somehow our own immunity can be boosted in a natural way to combat COVID-19 or other stubborn IDs, perhaps the world could have different.
With this goal in mind, I plan the conference on Infectious Disease, Microbiome, and public Health--In the current scenario.
The objective is to understand the global trend in microbiome and probiotics to deal with an outbreak associated with Infectious diseases. To achieve the milestones, we plan an online conference for two days. The conference is planned for August 10-11, 2020.
The challenge of a virtual conference is the time-zone of various speakers and participants. Keeping that in mind, we will perhaps start the meeting in the afternoon or evening of India.
There will be scope of e-posters and a few brief oral presentations by junior participants. Kindly register. Posters and oral presentations will be selected from the submitted abstracts. Due to time restrictions, only a handful of abstracts will be selected. Please note that keeping in mind the bandwidth and other limitations of the virtual or online meetings, we might be restricting the total number of participants to the first 50.
Registration : (Maximum number of participants reached. The registration is closed for this conference.)
Here are some of our speakers
Evolution of Vaccinology
Using Networks to Link Genotype to Phenotype
The Role of Probiotic Foods in Building Immunity
Bats, viruses and pandemics
The interaction in the liminal space between the Indian biotech/medtech entrepreneurial ecosystem and the Indian public health ecosystem: lessons in translational R&D
Characterizing Tissue-Barrier Specific Pathogenesis of Epidemic and Pandemic Emerging Viruses
Structure biology of pandemic viruses – lessons learnt on biology, pathomechanism and spread
Gut-lung axis: Can healthy gut microbiome protect against respiratory viral infections?
Overview on the PPP - Healthcare Innovation Scenario in the Current Times
Here information of schedule
Give your Feedback here